The reprieve would ease disruptions in Malaysia’s energy supply, but the prime minister has vowed to make preparations for a more volatile future. By Zunaira Saieed Reporting from Kuala Lumpur, ...

Dan Raby, the senior digital producer for CBS News Atlanta, has been covering everything happening around Georgia for more than a decade. Global biopharmaceutical company UCB, Inc. has named Gwinnett ...

FILE - The North American headquarters of Belgian pharmaceutical company UCB is seen, Nov. 10, 2014, in Smyrna, Ga. (Paul Abell/AP Images for UCB, Inc., File) (Paul Abell) ATLANTA – Belgian ...

UCB plans to build a $2 billion manufacturing facility near its U.S. headquarters in Atlanta, Georgia. It will become the first plant in the U.S. for the Belgium-based company and will produce ...

Delhi Capitals' KL Rahul celebrates his half century during an Indian Premier League (IPL) 2025 T20 cricket match between Royal Challengers Bengaluru and Delhi Capitals, at the M Chinnaswamy Stadium, ...

Malaysia’s government has been forced onto the defensive over its much-touted tariff deal with the United States, after a minister walked back an earlier claim that the agreement had been rendered ...

The Board of Control for Cricket in India (BCCI) on Sunday hosted the annual Naman Awards in New Delhi, where the country's five ICC World Cup-winning teams from the 2025/26 season were honoured.

Malaysia has declared the trade deal with the U.S. invalid after the Supreme Court ruled President Donald Trump‘s tariffs imposed under the International Emergency Economic Powers Act (IEEPA) illegal ...

Malaysia has withdrawn from a trade agreement with the United States, becoming the first country to abandon a pact negotiated under Washington’s reciprocal tariff strategy after a court ruling removed ...

In the months following Elon Musk’s $44 billion acquisition of Twitter in 2022, my experience with the platform (and perhaps yours too) got quickly, dramatically worse. My algorithmic timeline, better ...

Belgian biopharma company UCB (UCBJY) announced on Wednesday that its arthritis therapy Bimzelx outperformed AbbVie’s (ABBV) immunology therapy Skyrizi in a head-to-head trial for psoriatic arthritis, ...

UCB has entered the red-hot T-cell engager (TCE) space by paying $80 million for the rights to a Chinese biotech’s preclinical autoimmune candidate. At the center of the deal is ATG-201, a CD19/CD3 ...